Ranit Aharonov
Ranit Aharonov
IBM Research AI (previous: Rosetta Genomics)
Verified email at il.ibm.com
Cited by
Cited by
Identification of hundreds of conserved and nonconserved human microRNAs
I Bentwich, A Avniel, Y Karov, R Aharonov, S Gilad, O Barad, A Barzilai, ...
Nature genetics 37 (7), 766-770, 2005
MicroRNAs accurately identify cancer tissue origin
N Rosenfeld, R Aharonov, E Meiri, S Rosenwald, Y Spector, M Zepeniuk, ...
Nature biotechnology 26 (4), 462-469, 2008
MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues
O Barad, E Meiri, A Avniel, R Aharonov, A Barzilai, I Bentwich, U Einav, ...
Genome research 14 (12), 2486-2494, 2004
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non–small-cell lung carcinoma
D Lebanony, H Benjamin, S Gilad, M Ezagouri, A Dov, K Ashkenazi, ...
Journal of clinical oncology 27 (12), 2030-2037, 2009
Micrornas and uses thereof
I Bentwich, A Avniel, Y Karov, R Aharonov
US Patent 7,709,616, 2010
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma
HI Pass, C Goparaju, S Ivanov, J Donington, M Carbone, M Hoshen, ...
Cancer research 70 (5), 1916-1924, 2010
A second-generation microRNA-based assay for diagnosing tumor tissue origin
E Meiri, WC Mueller, S Rosenwald, M Zepeniuk, E Klinke, TB Edmonston, ...
The oncologist 17 (6), 801, 2012
Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin
S Rosenwald, S Gilad, S Benjamin, D Lebanony, N Dromi, A Faerman, ...
Modern Pathology 23 (6), 814-823, 2010
A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma
H Benjamin, D Lebanony, S Rosenwald, L Cohen, H Gibori, N Barabash, ...
The Journal of Molecular Diagnostics 12 (6), 771-779, 2010
Prostate cancer-related nucleic acids
I Bentwich, A Avniel, Y Karov, R Aharonov
US Patent 7,642,348, 2010
Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary
GR Varadhachary, Y Spector, JL Abbruzzese, S Rosenwald, H Wang, ...
Clinical Cancer Research 17 (12), 4063-4070, 2011
Classification of the four main types of lung cancer using a microRNA-based diagnostic assay
S Gilad, G Lithwick-Yanai, I Barshack, S Benjamin, I Krivitsky, ...
The Journal of molecular diagnostics 14 (5), 510-517, 2012
Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer
A Weissmann-Brenner, M Kushnir, G Lithwick Yanai, R Aharonov, ...
International journal of oncology 40 (6), 2097-2103, 2012
Liver cancer-related nucleic acids
I Bentwich, A Avniel, Y Karov, R Aharonov
US Patent 7,592,441, 2009
Lung cancer-related nucleic acids
B Itzhak, A Avniel, Y Karov, R Aharonov
US Patent 7,825,229, 2010
Predicting progression of bladder urothelial carcinoma using micro RNA expression
E Rosenberg, J Baniel, Y Spector, A Faerman, E Meiri, R Aharonov, ...
BJU international 112 (7), 1027-1034, 2013
Microbes can help explain the evolution of host altruism
O Lewin-Epstein, R Aharonov, L Hadany
Nature communications 8 (1), 1-7, 2017
Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary
G Pentheroudakis, N Pavlidis, G Fountzilas, D Krikelis, A Goussia, ...
Molecular cancer 12 (1), 1-8, 2013
Accurate classification of metastatic brain tumors using a novel microRNA-based test
WC Mueller, Y Spector, TB Edmonston, BS Cyr, D Jaeger, U Lass, ...
The oncologist 16 (2), 165, 2011
Will it blend? blending weak and strong labeled data in a neural network for argumentation mining
E Shnarch, C Alzate, L Dankin, M Gleize, Y Hou, L Choshen, R Aharonov, ...
Proceedings of the 56th Annual Meeting of the Association for Computational …, 2018
The system can't perform the operation now. Try again later.
Articles 1–20